Article Information
vol. 32 no. 167
PubMed
Published By
Print ISSN
Online ISSN
History
- Received October 24, 2022
- Accepted December 4, 2022
- Published online February 21, 2023.
Copyright & Usage
Copyright ©The authors 2023 This version is distributed under the terms of the Creative Commons Attribution Licence 4.0.
Author Information
- 1Department of Respiratory Medicine, Pathology and Molecular Medicine, McMaster University, Hamilton, ON, Canada
- 2Firestone Institute for Respiratory Health, St Joseph's Healthcare, Hamilton, ON, Canada
- 3Service de Pneumologie A, Hôpital Bichat, APHP, Paris, France
- 4INSERM, Unité 1152, Université Paris Cité, Paris, France
- 5Keck Medicine of USC, Los Angeles, CA, USA
- 6National Heart and Lung Institute, Imperial College London, London, UK
- Corresponding author: Toby M. Maher (Toby.Maher{at}med.usc.edu)
Funding
Boehringer Ingelheim
Article usage
Altmetrics
Vol 32 Issue 167
Table of Contents
Phosphodiesterase 4B inhibition: a potential novel strategy for treating pulmonary fibrosis
